AACR
CORZ icon

ACR Alpine Capital Research’s Core Scientific CORZ Stock Holding History

ACR Alpine Capital Research’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-155,000
Closed -$2.78M – 35
2025
Q3 		$2.78M Sell
155,000
-78,000
-33% -$1.14M 0.05% 30
2025
Q2 		$3.98M Buy
233,000
+25,000
+12% +$250K 0.07% 24
2025
Q1 		$1.51M Buy
208,000
+85,000
+69% +$967K 0.03% 32
2024
Q4 		$1.73M Sell
123,000
-53,100
-30% -$784K 0.04% 34
2024
Q3 		$2.09M Buy
+176,100
New +$1.82M 0.06% 28

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

ACR Alpine Capital Research's CORZ Position: Q4 2025 in Review

ACR Alpine Capital Research sold out of Core Scientific (CORZ) in Q4 2025, closing a stake of 155,000 shares — an estimated $2.78M sold.

ACR Alpine Capital Research first reported a position in CORZ in Q3 2024 and held it in 5 quarters. The position peaked at $3.98M in Q2 2025. 367 funds tracked by Wall St. Rank hold CORZ as of Q4 2025.

  • ACR Alpine Capital Research reported no remaining Core Scientific position as of Q4 2025 after selling out during the quarter.
  • ACR Alpine Capital Research sold 155,000 Core Scientific shares in Q4 2025, an estimated $2.78M.
  • ACR Alpine Capital Research first reported a position in Core Scientific in Q3 2024 and held it in 5 quarters.
  • ACR Alpine Capital Research's Core Scientific position peaked at $3.98M in Q2 2025.
  • 367 funds tracked by Wall St. Rank held Core Scientific as of Q4 2025.

Based on ACR Alpine Capital Research's 13F filing for Q4 2025, filed 5 Feb 2026.